|Daily Range||$35.84 - $37.43|
|52-Week Range||$16.71 - $45.00|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||773,835|
|Current FY EPS||-$2.59|
Prothena Corporation (PRTA) Description
Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/
News & Commentary
These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.
Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.